DCM
OMCL icon

Delpha Capital Management’s Omnicell OMCL Stock Holding History

Delpha Capital Management’s Portfolio OMCL Stock Details OMCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-80
Closed -$4K – 880
2017
Q4 		$4K Buy
+80
New +$4.04K ﹤0.01% 1361

Other funds holding OMCL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.98B AUM 60.71% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Delpha Capital Management's OMCL Position: Q1 2018 in Review

Delpha Capital Management sold out of Omnicell (OMCL) in Q1 2018, closing a stake of 80 shares — an estimated $4K sold.

Delpha Capital Management first reported a position in OMCL in Q4 2017 and held it in 1 quarter. The position peaked at $4K in Q4 2017. 231 funds tracked by Wall St. Rank hold OMCL as of Q1 2018.

  • Delpha Capital Management reported no remaining Omnicell position as of Q1 2018 after selling out during the quarter.
  • Delpha Capital Management sold 80 Omnicell shares in Q1 2018, an estimated $4K.
  • Delpha Capital Management first reported a position in Omnicell in Q4 2017 and held it in 1 quarter.
  • Delpha Capital Management's Omnicell position peaked at $4K in Q4 2017.
  • 231 funds tracked by Wall St. Rank held Omnicell as of Q1 2018.

Based on Delpha Capital Management's 13F filing for Q1 2018, filed 11 May 2018.